PureTech Health plc
PRTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5 | $3 | $2 | $10 |
| % Growth | 45% | 59.3% | -79.1% | – |
| Cost of Goods Sold | $0 | $5 | $152 | $110 |
| Gross Profit | $1 | -$2 | -$137 | -$100 |
| % Margin | 26% | -48.1% | -6,546.2% | -1,007% |
| R&D Expenses | $54 | $96 | $116 | $82 |
| G&A Expenses | $27 | $25 | $36 | $31 |
| SG&A Expenses | $27 | $48 | $36 | $31 |
| Sales & Mktg Exp. | $0 | $23 | $0 | $0 |
| Other Operating Expenses | $59 | -$90 | -$91 | $48 |
| Operating Expenses | $140 | $55 | $61 | $160 |
| Operating Income | -$136 | -$146 | -$198 | -$150 |
| % Margin | -2,818.9% | -4,390.4% | -9,464.4% | -1,506% |
| Other Income/Exp. Net | $160 | $110 | $105 | $91 |
| Pre-Tax Income | $24 | -$36 | -$93 | -$59 |
| Tax Expense | -$4 | $31 | -$56 | $4 |
| Net Income | $54 | -$66 | -$50 | -$61 |
| % Margin | 1,108.3% | -1,972.9% | -2,409.3% | -606.9% |
| EPS | 2 | -2.4 | -1.8 | -2.1 |
| % Growth | 183.3% | -33.3% | 14.3% | – |
| EPS Diluted | 2 | -2.4 | -1.8 | -2.1 |
| Weighted Avg Shares Out | 27 | 28 | 28 | 29 |
| Weighted Avg Shares Out Dil | 27 | 28 | 28 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $23 | $16 | $6 | $0 |
| Interest Expense | $10 | $13 | $4 | $5 |
| Depreciation & Amortization | $4 | $5 | $9 | $7 |
| EBITDA | $37 | -$12 | -$189 | $27 |
| % Margin | 774.3% | -349.2% | -9,038.9% | 267.6% |